Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Karuna Therapeutics, Inc.    KRTX

KARUNA THERAPEUTICS, INC.

(KRTX)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2020 02/13/2020 02/14/2020 02/18/2020 02/19/2020 Date
96.61(c) 96.11(c) 99.72(c) 102.49(c) 102.62 Last
126 784 222 087 213 302 526 016 28 008 Volume
-1.36% -0.52% +3.76% +2.78% +0.13% Change
More quotes
Financials (USD)
Sales 2019 -
EBIT 2019 -47,5 M
Net income 2019 -48,8 M
Finance 2019 292 M
Yield 2019 -
Sales 2020 -
EBIT 2020 -69,9 M
Net income 2020 -72,6 M
Finance 2020 255 M
Yield 2020 -
P/E ratio 2019 -48,8x
P/E ratio 2020 -37,7x
EV / Sales2019 -
EV / Sales2020 -
Capitalization 2 666 M
More Financials
Company
More about the company
Latest news on KARUNA THERAPEUTICS, INC.
02/06KARUNA THERAPEUTICS : Provides Update on its Discovery Research Efforts
BU
01/23PureTech Health Cuts Karuna Therapeutics Stake to 20.4%
DJ
01/09KARUNA THERAPEUTICS : to Present at the 38th Annual J.P. Morgan Healthcare Confe..
BU
2019KARUNA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2019KARUNA THERAPEUTICS : to Present at the Piper Jaffray 31st Annual Healthcare Con..
BU
2019KARUNA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2019KARUNA THERAPEUTICS : Announces Pricing of $250 Million Public Offering of Commo..
BU
2019LONDON STOCK EXCHANGE : FTSE up for third day on China stimulus hopes, Halma jum..
RE
2019KARUNA THERAPEUTICS : Announces Proposed Public Offering of Common Stock
BU
2019KARUNA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2019KARUNA THERAPEUTICS : Announces KarXT Met Primary Endpoint in Phase 2 Clinical T..
BU
2019KARUNA THERAPEUTICS : Schedules Webcast and Conference Call to Announce Results ..
BU
2019KARUNA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
AQ
2019KARUNA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Finan..
AQ
2019KARUNA THERAPEUTICS : Reports Third Quarter 2019 Financial Results and Provides ..
BU
More news
News in other languages on KARUNA THERAPEUTICS, INC.

- No features available -

More news
Sector news : Bio Therapeutic Drugs
09:08aGILEAD SCIENCES : Names Quigley as Senior Vice President of Research Biology
DJ
02/18Sanofi to Work on Coronavirus Vaccine
DJ
02/18Gilead's Coronavirus Drug Trial Slowed Due to Lack of Eligible Recruits
DJ
02/12Coronavirus-Drug Development Becomes a Top Focus at Gilead
DJ
02/12GILEAD SCIENCES : Correction to Report About Gilead Sciences' Work on a Coronavi..
DJ
More sector news : Bio Therapeutic Drugs
Chart KARUNA THERAPEUTICS, INC.
Duration : Period :
Karuna Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KARUNA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 121,00  $
Last Close Price 102,49  $
Spread / Highest target 33,7%
Spread / Average Target 18,1%
Spread / Lowest Target 2,45%
EPS Revisions
Sector and Competitors
1st jan.Capitalization (M$)
KARUNA THERAPEUTICS, INC.32.36%2 666
GILEAD SCIENCES3.97%84 777
VERTEX PHARMACEUTICALS12.32%63 762
REGENERON PHARMACEUTICALS6.41%43 287
WUXI APPTEC CO., LTD.23.75%26 550
GENMAB10.23%15 693